This article is more than 5 years old. Information may no longer be current.

ACOG issues updated recommendations on use of aspirin for preeclampsia prevention

The American College of Obstetricians and Gynecologists supports guidelines issued by the United States Preventive Services Task Force on the use of low-dose aspirin for the prevention of preeclampsia.

According to a practice advisory from the group, the USPSTF recommendations are more expansive in identifying women at high risk for developing preeclampsia.

"ACOG supports the recommendation to consider the use of low-dose aspirin (81 mg/day), initiated between 12 and 28 weeks of gestation, for the prevention of preeclampsia, and recommends using the high-risk factors as recommended by the USPSTF," the group wrote.

These risk factors include: renal disease, diabetes, multifetal gestation, chronic hypertension, history of preeclampsia and autoimmune diseases.

Previously, the group had based its recommendations on efforts from the Task Force on Hypertension in Pregnancy. Those recommendations supported "the use of low-dose aspirin, beginning in the late first trimester, ... for women with a history of early-onset preeclampsia and preterm delivery at less than 34 0/7 weeks gestation, or in women with more than one prior pregnancy complicated by preeclampsia."